Table 4.

Studies conducted in the Research Department of influenza viruses, the National Influenza Center, NIPH in collaboration with clinicians in the groups at risk and evaluated the humoral immune response to influenza vaccination [1] (Brydak L.B. 2008).

Children
Children aged 6–35 months, 3–8 years of age, 9–12 years 0.13–20 years of age
Children with acute lymphoblastic leukemia (ALL), vaccinated at different times after treatment.
Children with severe haemophilia and mild.
Children with bronchopulmonary dysplasia.
Children with glomerulonephritis.
Children with chronic renal failure subjected to continuous ambulatory peritoneal dialysis, hemodialysis and chronic renal failure vaccinated once and twice.
Children infected with HIV.
Children vaccinated after splenectomy in age groups 0–5 years of age, 6–10 years of age, 11–15 years of age, (dissertation)
Children with aplastic anaemia
Children with asthma
Children with inflammatory bowel disease
Adults
Adults aged 1921–1930 years of age, from 1931 to 1940 years of age, from 1941 to 1950 years of age, from 1951 to 1964 years of age, >64 years (2 dissertations)
Billeted students of the Military Medical Academy
Patients chronically ill
Patients with acute lymphoblastic leukemia
Patients with chronic renal failure
Patients after renal allograft resipients
Patients infected with HIV at various levels of CD4, with symptoms of AIDS and asymptomatic
Patients with breast cancer
Patients with cancer of the thyroid
Patients with asthma (part of PhD thesis)
Patients with chronic obstructive pulmonary disease (COPD) (part of PhD thesis)
Patients with a group of young and elderly (dissertation)
Patients with acute cardiovascular events (some of the habilitation thesis)
Patients with malignant lymphomas-Hodgkin’s (PhD thesis)
Patients with lupus (PhD thesis)
Patients with primary systemic vascular inflammation: Wegner’s granulomatosis (part of the habilitation thesis)